Search This Site:
Beds-Luton-MK-CCG-Logo-2021

JPC Bulletin

Bedfordshire and Luton Joint Prescribing Committee

Ref: JPC Bulletin 213
Bulletin Date: 16/02/15
Review Date: February 2017

Bulletin 213 Eltrombopag (Revolade®) for the treatment of thrombocytopenia in adult patients with chronic hepatitis C virus infection

JPC Recommendations:

Eltrombopag(Revolade) for the treatment of thrombocytopenia in adult patients with chronic hepatitis C virus infection, where degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy.

The JPC agreed to support the attached East of England Priorities Advisory Committee (EoEPAC) Guidance Statement (see attached).

Additional Information:

Scroll to Top